Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Yasuda

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
European Urology Oncology|December 14, 2022
Comprehensive Management of Renal Masses in Solitary KidneysYosuke Yasuda, Jj H Zhang, Worapat Attawettayanon, et al.
Cancers|May 13, 2026
C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell CarcinomaAaron I Ahdoot, Cesare Saitta, Giuseppe Garofano, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
European Urology Oncology|December 14, 2022
Comprehensive Management of Renal Masses in Solitary KidneysYosuke Yasuda, Jj H Zhang, Worapat Attawettayanon, et al.
Cancers|May 13, 2026
C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell CarcinomaAaron I Ahdoot, Cesare Saitta, Giuseppe Garofano, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Pageof 10